novo nordisk cagrilintide shares plunge after CagriSema obesity drug trial disappoints Wegovy Maker Novo Nordisk Files
Description
[00:19] Jamie Lots going on, man
doi: 10.1136/bmj.b2535
The exercises that felt impossible or shaky in Week 1 now feel stable

& Kupfer, D